ADME/PK as part of a rational approach to drug discovery-Reference-Cited by-同舟云学术

ADME/PK as part of a rational approach to drug discovery

Published:2000-09 Issue:9 Volume:5 Page:409-414
ISSN:1359-6446
Container-title:Drug Discovery Today
language:en
Short-container-title:Drug Discovery Today

Author:

Eddershaw Peter J,Beresford Alan P,Bayliss Martin K

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference28 articles.

1. Managing the drug discovery/development interface;Kennedy;Drug Discovery Today,1997

2. Pharmaceutical innovation by the seven UK-owned pharmaceutical companies (1964–1985);Prentis;Br. J. Clin. Pharmacol.,1988

3. Microtiter plate assays for inhibition of human, drug-metabolizing cytochromes P450;Crespi;Anal. Biochem.,1997

4. Fully automated analysis of activities catalysed by the major human liver cytochrome P450 (CYP) enzymes: assessment of human CYP inhibition potential;Moody;Xenobiotica,1999

5. Compound optimization in early- and late-phase drug discovery: acceptable pharmacokinetic properties utilizing combined physicochemical, in vitro and in vivo screens;Caldwell;Curr. Opin. Drug Discov.,2000

Cited by 193 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Isosorbide, a versatile green chemical: Elucidating its ADME properties for safe use;Ecotoxicology and Environmental Safety;2024-03

2. Discovery of new piperaquine hybrid analogs linked by triazolopyrimidine and pyrazolopyrimidine scaffolds with antiplasmodial and transmission blocking activities;European Journal of Medicinal Chemistry;2024-03

3. Repurposing iron chelators for accurate positron emission tomography imaging tracking of radiometal‐labeled cell transplants;MedComm;2024-01-30

4. Fragment-based drug nanoaggregation reveals drivers of self-assembly;Nature Communications;2023-12-14

5. Virtual Screening of Orally Active Lead Compounds of Pearl Millet and Their Structural Activity Against Target Protein of COVID-19;Russian Journal of Bioorganic Chemistry;2023-12